Patients with HRR-deficient metastatic castration-resistant prostate cancer experienced a 14-month gain in OS and a 38% lower ...
Ten people will go into the Tasmanian wilderness for Alone Australia, in the hopes of winning $250,000. Read more about them here.
Avelumab maintenance with axitinib interruption was feasible in metastatic renal cell carcinoma responders, according to ...
22hon MSNOpinion
Honest Democrats have acknowledged that President Donald Trump and Elon Musk are fixing problems that should have been ...
A small population of California burrowing owls is getting a helping hand when it comes to romance—from a team of devoted ...
Elden Ring Nightreign is a standalone multiplayer co-op action survival game that challenges players to band together in order to defeat the Nightlord.
Thousands more breast cancers could be detected earlier in England next year in a major new NHS drive to support more women to attend potentially life-saving breast screening. The NHS in England has ...
5d
talker on MSNLoneliest bat finally finds mate in time for Valentine’s DayThe bat species hails from France and was considered to be endangered. The post Loneliest bat finally finds mate in time for ...
Single’s Inferno Season 4 ends as every season of the hit Korean reality dating show does: with a host of young, hot single ...
16hOpinion
Korea Joongang Daily on MSNAging cities, crumbling safetyAs the frequency of sinkhole incidents increases worldwide, governments must prioritize long-term infrastructure planning.
Patients with mCRPC taking LuPSMA had a median OS of 34 months vs 26 months with enzalutamide alone.
Amezalpat has been granted FDA fast track designation as treatment for patients with hepatocellular carcinoma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results